GRIT Biotechnology Funding: $60M Raised, Series B

GRIT Biotechnology is based in Shanghai, China. It has raised $60M in total funding. Latest round: Series B. Backed by CICC Capital, Decheng Capital.

GRIT Biotechnology funding overview

GRIT Biotechnology is based in Shanghai, China. GRIT Biotechnology has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include CICC Capital, Decheng Capital. 2 distinct backers are named across the disclosed rounds.

GRIT Biotechnology at a glance

Total raised
$60M
Latest round
Series B
Headquarters
Shanghai, China
Notable investors
CICC Capital, Decheng Capital

Frequently asked about GRIT Biotechnology funding

How much has GRIT Biotechnology raised?
GRIT Biotechnology has raised $60M in total disclosed funding across the rounds on record.
Who has invested in GRIT Biotechnology?
CICC Capital, Decheng Capital are named among the investors backing GRIT Biotechnology.
What was the latest GRIT Biotechnology funding round?
The most recent disclosed round is a Series B.
Where is GRIT Biotechnology based?
GRIT Biotechnology is based in Shanghai, China.

Totals shown for GRIT Biotechnology aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.

Companies related to GRIT Biotechnology (36)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026